However, while in children flu could start out as a trivial form, in the elderly, in the immunocompromised subjects or in other people “at risk” (i.e chronically debilitated patients or even neoplastic), pulmonary and cardiac complications may come out and be life-threatening.
It is a phenomenon we are going to have to deal with, more and more, if we do not introduce new antimicrobial molecules.
Antibiotic resistance results in the ineffectiveness of antibiotic therapy, with longer duration of both therapy and hospitalization, moreover could even lead to a poor prognosis of the patients.
Albeit, considering that some hospital care practices (i.e. major surgery), high-intensity care environments (such as intensive care units) or even cancer and post-transplant therapies, have certainly improved patient survival, unfortunately we must be aware that all these conditions could promote the onset of infections, even by opportunistic germs.